Marina Karakantza - Publications

G-CSF Only Versus Chemotherapy and G-CSF Peripheral Blood Stem Cell Mobilization for Autologous Hematopoietic Stem Cell Transplant-Assessing a Change in Regime due to the COVID-19 Pandemic.

Journal: Journal of clinical apheresis

Published: September 25, 2024

Mechanistic insights from a pilot exploratory study of the dynamic proteomic changes during plasma exchange in patients with acute liver failure.

Journal: Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis

Published: August 27, 2024

A comparison of peripheral blood stem cell collection outcomes for multiple myeloma; mobilization matters in the era of IMiD induction.

Journal: EJHaem

Published: April 13, 2023

Apparent changes in RhD status during pregnancy: A case study of weak D variant due to RHD*DAU-2.

Journal: Transfusion medicine (Oxford, England)

Published: March 24, 2023

High Frequency of Post-Transfusion Microchimerism Among Multi-Transfused Beta-Thalassemic Patients.

Journal: Frontiers in medicine

Published: December 29, 2021

Thrombocytopenia and platelet transfusion in myelodysplastic syndromes.

Journal: Transfusion

Published: September 09, 2020

Hematological Malignancy Specific Patient-Reported Outcome Measure (HM-PRO): Construct Validity Study.

Journal: Frontiers in pharmacology

Published: June 09, 2020

Reliability of a Novel Hematological Malignancy Specific Patient-Reported Outcome Measure: HM-PRO.

Journal: Frontiers in pharmacology

Published: June 09, 2020

Quality-of-life issues and symptoms reported by patients living with haematological malignancy: a qualitative study.

Journal: Therapeutic advances in hematology

Published: March 31, 2020

Evaluation of the Activity of Neutrophils and Monocytes in Diabetic Patients With Sepsis, Can Surface Antigens HLA-DR and CD64 Be Useful as Prognostic Factors?

Journal: Journal of clinical medicine research

Published: December 11, 2019

Red cell transfusion in outpatients with myelodysplastic syndromes: a feasibility and exploratory randomised trial.

Journal: British journal of haematology

Published: September 09, 2019

Development of a Novel Hematological Malignancy Specific Patient-Reported Outcome Measure (HM-PRO): Content Validity.

Journal: Frontiers in pharmacology

Published: May 17, 2019